Page 1333 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

2 References

28. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus 44. Karlsson H, Brewin J, Kinnon C, et al. Generation of trispecific
Conference on Acute GVHD Grading. Bone Marrow Transplant. cytotoxic T cells recognizing cytomegalovirus, adenovirus, and
1995;15:825-828. Epstein-Barr virus: an approach for adoptive immunotherapy of
29. Cahn JY, Klein JP, Lee SJ, et al. Prospective evaluation of 2 acute multiple pathogens. J Immunother. 2007;30:544-556.
graft-versus-host (GVHD) grading systems: a joint Societe 45. Debur MC, Vidal LR, Stroparo E, et al. Human metapneumo-
Francaise de Greffe de Moelle et Therapie Cellulaire (SFGM-TC), virus infection in hematopoietic stem cell transplant recipients.
Dana Farber Cancer Institute (DFCI), and International Bone Transpl Infect Dis. 2010;12(2):173-179.
Marrow Transplant Registry (IBMTR) prospective study. Blood. 46. Yoshihara S, Yanik G, Cooke KR, et al. Bronchiolitis obliterans
2005;106:1495-1500. syndrome (BOS), bronchiolitis obliterans organizing pneumonia
30. Korngold R. Biology of graft-vs.-host disease. Am J Pediatr (BOOP), and other late-onset noninfectious pulmonary complica-
Hematol Oncol. 1993;15:18-27. tions following allogeneic hematopoietic stem cell transplantation.
31. MacMillan ML, Weisdorf DJ, Wagner JE, et al. Response of 443 Biol Blood Marrow Transplant. 2007;13:749-59. 46.
patients to steroids as primary therapy for acute graft-versus- 47. Clark JG, Hansen JA, Hertz MI, et al. NHLBI workshop sum-
host disease: comparison of grading systems. Biol Blood Marrow mary. Idiopathic pneumonia syndrome after bone marrow
Transplant. 2002;8:387-394. transplantation. Am Rev Respir Dis. 1993;147:1601-1606.
32. Korngold R, Antin JH. Biology and management of acute 48. Afessa B, Peters SG. Noninfectious pneumonitis after blood and
graft-versus-host disease. Cancer Treat Res. 2009;144:257-275. marrow transplant. Curr Opin Oncol. 2008;20:227-233.
33. Ringden O, Uzunel M, Rasmusson I, et al. Mesenchymal stem 49. Kotloff RM, Ahya VN, Crawford SW. Pulmonary complications
cells for treatment of therapy-resistant graft-versus-host disease. of solid organ and hematopoietic stem cell transplantation. Am
Transplantation. 2006;81:1390-1397. Rev Respir Crit Care Med. 2004;170:22-48.
34. Martin PJ, Pavletic SZ. Biology and management of chronic 50. Cooke KR, Yanik G. Acute lung injury after allogeneic stem cell
graft-versus-host disease. Cancer Treat Res. 2009;144:277-298. transplantation: is the lung a target of acute graft-versus-host
disease? Bone Marrow Transplant. 2004;34:753-765.
35. Lee SJ, Klein JP, Barrett AJ, et al. Severity of chronic graft-
versus-host disease: association with treatment-related 51. De Lassence A, Fleury-Feith J, Escudier E, et al. Alveolar
mortality and relapse. Blood. 2002;100:406-414. hemorrhage. Diagnostic criteria and results in 194 immunocom-
promised hosts. Am J Respir Crit Care Med. 1995;151:157-163.
36. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes
of Health consensus development project on criteria for clinical 52. Afessa B, Tefferi A, Litzow MR, et al. Diffuse alveolar hemor-
trials in chronic graft-versus-host disease: I. Diagnosis and rhage in hematopoietic stem cell transplant recipients. Am J
staging working group report. Biol Blood Marrow Transplant. Respir Crit Care Med. 2002;166:641-645.
2005;11:945-956. 53. Hicks K, Peng D, Gajewski JL. Treatment of diffuse alve-
37. Couriel DR, Hosing C, Saliba R, et al. Extracorporeal photo- olar hemorrhage after allogeneic bone marrow transplant
chemotherapy for the treatment of steroid-resistant chronic with recombinant factor VIIa. Bone Marrow Transplant.
GVHD. Blood. 2006;107:3074-3080. 2002;30(12):975-978.
38. Couriel D, Carpenter PA, Cutler C, et al. Ancillary therapy and 54. Pastores SM, Papadopoulos E, Voigt L, et al. Diffuse alveolar
supportive care of chronic graft-versus-host disease: National hemorrhage after allogeneic hematopoietic stem-cell transplan-
Institutes of Health consensus development project on crite- tation: treatment with recombinant factor VIIa. Chest. 2003;
ria for clinical trials in chronic graft-versus-host disease: V. 124:2400-2403.
Ancillary Therapy and Supportive Care Working Group Report. 55. Shenoy A, Savani BN, Barrett AJ. Recombinant factor VIIa to
Biol Blood Marrow Transplant. 2006;12:375-396. treat diffuse alveolar hemorrhage following allogeneic stem
39. Kamboj M, Chung D, Seo SK, et al. The changing epidemiology cell transplantation. Biol Blood Marrow Transplant. 2007;13(5):
of vancomycin-resistant enterococcus (VRE) bacteremia in allo- 622-623.
geneic hematopoietic stem cell transplant (HSCT) recipients. 56. Capizzi SA, Kumar S, Huneke NE, et al. Peri-engraftment respira-
Biol Blood Marrow Transplant. 2010;16:1576-1581. tory distress syndrome during autologous hematopoietic stem cell
40. Almyroudis NG, Segal BH. Antifungal prophylaxis and therapy transplantation. Bone Marrow Transplant. 2001;27:1299-1303.
in patients with hematological malignancies and hematopoietic 57. Kishi Y, Kami M, Miyakoshi S, et al. Early immune reaction
stem cell transplant recipients. Expert Rev Anti Infect Ther. 2010; after reduced-intensity cord-blood transplantation for adult
8:1451-1466. patients. Transplantation. 2005;80:34-40.
41. Kontoyiannis DP. Antifungal prophylaxis in hematopoietic 58. Patel KJ, Rice RD, Hawke R, et al. Pre-engraftment syndrome
stem cell transplant recipients: the unfinished tale of imperfect after double-unit cord blood transplantation: a distinct syn-
success. Bone Marrow Transplant. February 2011;46(2):165-173. drome not associated with acute graft-versus-host disease. Biol
42. Hanley PJ, Cruz CRY, Savoldo B, et al. Functionally active virus- Blood Marrow Transplant. 2010;16:435-440.
specific T cells that target CMV, adenovirus, and EBV can be 59. Spitzer TR. Engraftment syndrome following hematopoietic
expanded from naive T-cell populations in cord blood and will stem cell transplantation. Bone Marrow Transplant. 2001;27:
target a range of viral epitopes. Blood. 2009;114:1958-1967. 893-898.
43. Bao L, Dunham K, Stamer M, et al. Expansion of cytomega- 60. Chien JW, Duncan S, Williams KM, et al. Bronchiolitis oblit-
lovirus pp65 and IE-1 specific cytotoxic T lymphocytes for erans syndrome after allogeneic hematopoietic stem cell
cytomegalovirus-specific immunotherapy following alloge- transplantation-an increasingly recognized manifestation of
neic stem cell transplantation. Biol Blood Marrow Transplant. chronic graft-versus-host disease. Biol Blood Marrow Transplant.
2008;14:1156-1162. 2010;16:S106-S114.

Section07-O-ref.indd 2 1/21/2015 11:26:51 AM